<?xml version="1.0" encoding="UTF-8"?>
<ref id="B40-pharmaceutics-13-00379">
 <label>40.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Hamamura</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Katsuyama</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Komatsu</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Scuteri</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Bagetta</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Aritake</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Sakurada</surname>
    <given-names>T.</given-names>
   </name>
  </person-group>
  <article-title>Behavioral Effects of Continuously Administered Bergamot Essential Oil on Mice with Partial Sciatic Nerve Ligation</article-title>
  <source>Front. Pharmacol.</source>
  <year>2020</year>
  <volume>11</volume>
  <fpage>1310</fpage>
  <pub-id pub-id-type="doi">10.3389/fphar.2020.01310</pub-id>
  <?supplied-pmid 32973528?>
  <pub-id pub-id-type="pmid">32973528</pub-id>
 </element-citation>
</ref>
